VIDO-InterVac

Vaccine and Infectious Disease Organization -
International Vaccine Centre

Peter Brenders

Mr. Brenders was appointed Chief Executive Officer of Inagene Diagnostics Inc. in 2018.  Previously he was Canadian General Manager at Sanofi Genzyme for almost 7 years and he was President & CEO of BIOTECanada for almost eight years prior. Peter has worked in senior management roles in health affairs at Genzyme and Schering-Plough Canada and worked in the Ontario Ministry of Health and in the health consulting practice at KPMG. Peter is currently a member of the board of directors of VIDO-InterVac and The Cameron Institute and a member of the Life Sciences Advisory Group of Global Affairs Canada. He also serves as an advisor to mitoNET, Kalgene Pharma, and the Professional Advisory Council for the MMASc of Western University. He has served as a member of the board of Research Canada, the Advisory Board for the National Research Council's (NRC) Institute for Marine Biosciences and the NRC's Institute for Nutrisciences and Health, the Canadian Agri-Food Policy Institute Advisory Board, and was an Industry Advisor for the Atlantic Canada Opportunity Agency's Atlantic Innovation Fund Committees for Aquaculture and Biotechnology Sector and Health and Medical Sector. Peter received his MBA in Health Services Management from McMaster University. Prior to his brief work in basic research at the Robarts Research Institute, he received his Honours BSc in Pharmacology and Toxicology from the University of Western Ontario. Peter was inducted in to the Canadian Healthcare Marketing Hall of Fame in 2016.